Clinical Trials
3 trialsNCT06541067 2026-01-26
POSALLO
Nantes University Hospital
Phase 2 Recruiting
NCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00750737 2016-09-29
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
M.D. Anderson Cancer Center
Phase 3 Completed